oasis 1 oral semaglutide 50 mg nejm 2023 obesity 🥼🧪Slide Deck: Efficacy and safety of oral semaglutide 25 mg in adults with overweight/obesity: the OASIS 4 RCT : r/Semaglutide FDA approves once-daily oral Wegovy®

Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10Years in the CLARICOR randomised, blinded clinical trial

The Ozempic savings card works differently, reducing out-of-pocket costs to as little as $25 per month for up to 24 months for commercially insured patients

Patent Term Extension (PTE): Novo Nordisk has sought and received PTE for relevant patents on Ozempic to compensate for patent term lost during the regulatory review process

White labelling means selling a generic product that many other brands may also carry, which can make it hard to stand out

Over 12% of adults in the US say they have used a GLP-1 agonist, with brand names such as Ozempic and Mounjaro becoming household names